BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37709996)

  • 41. Abnormal regulation of in vitro IgG production in multiple sclerosis.
    Kelly RE; Ellison GW; Myers LW; Goymerac V; Larrick SB; Kelley CC
    Ann Neurol; 1981 Mar; 9(3):267-72. PubMed ID: 6452852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis.
    Oksenberg JR; Panzara MA; Begovich AB; Mitchell D; Erlich HA; Murray RS; Shimonkevitz R; Sherritt M; Rothbard J; Bernard CC; Steinman L
    Nature; 1993 Mar; 362(6415):68-70. PubMed ID: 7680433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
    Sharief MK; Semra YK
    Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple Sclerosis: New Aspects of Immunopathogenesis.
    Lazibat I; Rubinić Majdak M; Županić S
    Acta Clin Croat; 2018 Jun; 57(2):352-361. PubMed ID: 30431730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
    Höftberger R; Leisser M; Bauer J; Lassmann H
    Acta Neuropathol Commun; 2015 Dec; 3():80. PubMed ID: 26637427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4
    Faigle W; Cruciani C; Wolski W; Roschitzki B; Puthenparampil M; Tomas-Ojer P; Sellés-Moreno C; Zeis T; Jelcic I; Schaeren-Wiemers N; Sospedra M; Martin R
    Front Immunol; 2019; 10():540. PubMed ID: 31024521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis.
    Levitt D; Griffin NB; Egan ML
    J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.
    Van Kaer L; Postoak JL; Wang C; Yang G; Wu L
    Cell Mol Immunol; 2019 Jun; 16(6):531-539. PubMed ID: 30874627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of T-cell receptor V beta usage in the brain of a subject with multiple sclerosis.
    Shimonkevitz R; Murray R; Kotzin B
    Ann N Y Acad Sci; 1995 Jul; 756():305-6. PubMed ID: 7645846
    [No Abstract]   [Full Text] [Related]  

  • 50. T cell vaccination in multiple sclerosis.
    Zhang I; Raus J
    Mult Scler; 1996 Jul; 1(6):353-6. PubMed ID: 9345417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Higher expression of BDNF receptor gp145trkB is associated with lower apoptosis intensity in T cell lines in multiple sclerosis.
    De Santi L; Cantalupo L; Tassi M; Raspadori D; Cioni C; Annunziata P
    J Neurol Sci; 2009 Feb; 277(1-2):65-70. PubMed ID: 18992902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
    Wang J; Jelcic I; Mühlenbruch L; Haunerdinger V; Toussaint NC; Zhao Y; Cruciani C; Faigle W; Naghavian R; Foege M; Binder TMC; Eiermann T; Opitz L; Fuentes-Font L; Reynolds R; Kwok WW; Nguyen JT; Lee JH; Lutterotti A; Münz C; Rammensee HG; Hauri-Hohl M; Sospedra M; Stevanovic S; Martin R
    Cell; 2020 Nov; 183(5):1264-1281.e20. PubMed ID: 33091337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adherence of multiple sclerosis lymphocytes to measles infected cells.
    Frey H; Salmi A; Svedström E
    J Neurol; 1979 Mar; 220(2):99-104. PubMed ID: 87503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
    Armentrout SA; Sweet PM; Galant SP
    J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.
    O'Brien K; Gran B; Rostami A
    Immunotherapy; 2010 Jan; 2(1):99-115. PubMed ID: 20231863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination.
    Holley JE; Bremer E; Kendall AC; de Bruyn M; Helfrich W; Tarr JM; Newcombe J; Gutowski NJ; Eggleton P
    Mult Scler Relat Disord; 2014 Sep; 3(5):650-8. PubMed ID: 26265276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When encephalitogenic T cells collaborate with microglia in multiple sclerosis.
    Dong Y; Yong VW
    Nat Rev Neurol; 2019 Dec; 15(12):704-717. PubMed ID: 31527807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of CD4 T cells in the pathogenesis of multiple sclerosis.
    Chitnis T
    Int Rev Neurobiol; 2007; 79():43-72. PubMed ID: 17531837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis.
    Brinkman CJ; Nillesen WM; Hommes OR
    Acta Neurol Scand; 1984 Feb; 69(2):90-6. PubMed ID: 6231801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B and T lymphocytes in man. III. B, t, and "null" lymphocytes in multiple sclerosis.
    Reddy MM; Goh KO
    Neurology; 1976 Oct; 26(10):997-9. PubMed ID: 1085430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.